John G Ullman & Associates Inc Boston Scientific Corp Transaction History
John G Ullman & Associates Inc
- $624 Million
- Q2 2025
A detailed history of John G Ullman & Associates Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, John G Ullman & Associates Inc holds 1,874 shares of BSX stock, worth $182,377. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,874Holding current value
$182,377% of portfolio
0.03%Shares
2 transactions
Others Institutions Holding BSX
# of Institutions
1,910Shares Held
1.27BCall Options Held
9.71MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA137MShares$13.3 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.34 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.37 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.29 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $139B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...